Analysts at StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Trading Down 1.3 %
AEZS stock opened at $3.75 on Friday. The company has a market capitalization of $6.72 million, a P/E ratio of -0.26 and a beta of 1.55. The business has a 50 day simple moving average of $4.94 and a 200-day simple moving average of $6.53. Aeterna Zentaris has a twelve month low of $3.96 and a twelve month high of $12.00.
About Aeterna Zentaris
Featured Stories
- Five stocks we like better than Aeterna Zentaris
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Profitably Trade Stocks at 52-Week Highs
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Trading Halts Explained
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.